Overview

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)

Status:
Unknown status

Trial end date:
2017-07-01

Target enrollment:

Participant gender:

Summary

Paroxysmal nocturnal hemoglobinuria is an acquired chronic hemolytic anemia,this study is designed to evaluate the safety and efficacy of Levamisole combined with cyclosporine A in patients with Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the setting of another bone marrow failure syndromes

Phase:

Phase 2

Details

Lead Sponsor:

Institute of Hematology & Blood Diseases Hospital

Treatments:

Cyclosporine
Cyclosporins
Glucocorticoids
Levamisole